Johnson & Johnson’s (J&J) second-quarter profit soared 73 percent, thanks to strong sales growth across all of its businesses, particularly its medical device and diagnostics segment, as hospitals and the rest of the healthcare industry continued recovering from the effects of the coronavirus pandemic.The healthcare giant also got a boost from favourable currency exchange rates and hiked its sales and profit forecasts sharply for the year.The world’s biggest maker of healthcare products on Wednesday reported net income of $6.28bn, or $2.35 per share, in the quarter, up from $3.63bn, or $1.36 per share, a year earlier.
Load More
Load More